Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPA1P52 is a pseudogene related to the protein-coding gene "heterogeneous nuclear ribonucleoprotein A1" (HNRNPA1). Pseudogenes are segments of DNA that resemble protein-coding genes but have accumulated mutations rendering them non-functional for protein production[4]. HNRNPA1P52 does not produce a functional protein and is not considered a receptor, enzyme, or therapeutic target. While the parent gene HNRNPA1 encodes an abundant RNA-binding protein involved in RNA processing, splicing, and regulation—with wide implications for human biology and disease—HNRNPA1P52 itself has no known direct role in physiology or disease, nor does it interact with drugs or serve as a classical therapeutic target[1][4]. Pseudogenes can sometimes be transcribed and have emerging roles as regulatory RNAs or competing endogenous RNAs (ceRNAs) in some biological contexts, including cancer, but there is no specific evidence for HNRNPA1P52 in these functions to date[4]. Its identification as a pseudogene is correct, and it should not be confused with HNRNPA1, which is a well-characterized, functional RNA-binding protein. There is nothing functionally actionable about HNRNPA1P52 in terms of target pharmacology because it is a pseudogene and *not* a therapeutic target[1][4]. If you are seeking information about the active protein HNRNPA1, a separate and much broader profile would apply. This gene should not be considered a receptor, enzyme, transporter, or actual target; it is a non-coding pseudogene[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 52 (HNRNPA1P52).